A program to match cancer therapies to genetic changes in tumors
Vanderbilt Network Lead Academic Participating Site for the NCTN
['FUNDING_OTHER'] · VANDERBILT UNIVERSITY MEDICAL CENTER · NIH-10793499
This study is all about finding the best cancer treatments for you by looking at the unique genetic changes in your tumor, and it gives patients a chance to try new therapies that could help improve their care.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | VANDERBILT UNIVERSITY MEDICAL CENTER (nih funded) |
| Locations | 1 site (NASHVILLE, UNITED STATES) |
| Trial ID | NIH-10793499 on ClinicalTrials.gov |
What this research studies
This research focuses on improving cancer treatment by matching therapies to the specific genetic mutations found in patients' tumors. The Vanderbilt-Ingram Cancer Center utilizes advanced informatics and a personalized approach to identify the most effective treatments based on individual genetic profiles. Patients may have the opportunity to participate in clinical trials that explore new therapies and contribute to the understanding of cancer resistance mechanisms. The initiative also supports junior faculty in developing clinical trials, ensuring a robust pipeline of innovative treatments.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients with cancer who have specific genetic mutations that may be targeted by new therapies.
Not a fit: Patients without cancer or those whose tumors do not have actionable genetic alterations may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective, personalized cancer treatments that improve patient outcomes.
How similar studies have performed: Previous research has shown success in personalized cancer treatment approaches, indicating a promising potential for this initiative.
Where this research is happening
NASHVILLE, UNITED STATES
- VANDERBILT UNIVERSITY MEDICAL CENTER — NASHVILLE, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: CIOMBOR, KRISTEN KEON — VANDERBILT UNIVERSITY MEDICAL CENTER
- Study coordinator: CIOMBOR, KRISTEN KEON
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.